InfraScan lands FDA approval for next-gen non-invasive brain bleed detector

Mon, 01/21/2013 - 11:29am
Mass Device

InfraScan lands regulatory approval for its next-generation Infrascanner Model 2000, designed with military specifications for non-invasively detecting bleeding in the brain.

InfraScan's Infrascanner Model 2000

Philadelphia-based medical device maker InfraScan announced FDA approval for its next-generation non-invasive brain bleed detector, the Infrascanner Model 2000.

Developed in partnership with the U.S. Navy and Marine Corps, the Infrascanner 2000 is a more rugged generation of the company's original Infrascanner, which won FDA approval in 2011.

The Infrascanner line uses near-infrared technology to non-invasively detect bleeding in the skull, helping to identify which patients may need a CT scan and quick intervention.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.